Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
The efficiency and safety of Liraglutide Versus Placebo as an additional glucose-lowering therapy in patients with Type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomised clinical trial